Downloadable slideset from Clinical Care Options on with expert insight on emerging ART strategies, including rapid ART initiation and dual therapy.
Commentary from David A. Wohl, MD, on latest HIV conference data behind virologically suppressed patients switching to new 2- and 3-drug combinations.
Downloadable slideset covering key HIV studies presented at IDWeek, Comorbidities Workshop, and HIV Glasgow 2018, reported by Clinical Care Options
Study 1878: Suppression maintained through Week 48 after switch to BIC/FTC/TAF with M184V/I presented at Glasgow 2018 reported by Clinical Care Options
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.